Mink Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . Mink Therapeutics
INKT Stock  USD 11.04  0.01  0.09%   
Analyzing historical trends in various income statement and balance sheet accounts from Mink Therapeutics' financial statements helps investors evaluate the company's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Mink Therapeutics' valuation are summarized below:
Market Capitalization
51.8 M
Earnings Share
(3.01)
There are currently one hundred twenty fundamental ratios for Mink Therapeutics that can be evaluated and compared over time across peers in the industry. All traders should check Mink Therapeutics' last-minute fundamentals against the performance from 2010 to 2026 and make sure the trends continue to evolve in the right direction. Market Cap is likely to drop to about 28.5 M in 2026. Enterprise Value is likely to drop to about 28.9 M in 2026
Check Mink Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Mink Therapeutics' main balance sheet or income statement drivers, such as Net Interest Income of 208.4 K, Depreciation And Amortization of 130.5 K or Interest Expense of 216.6 K, as well as many indicators such as Price To Sales Ratio of 335, Dividend Yield of 0.0 or Days Sales Outstanding of 223. Mink financial statements analysis is a perfect complement when working with Mink Therapeutics Valuation or Volatility modules.
  
Build AI portfolio with Mink Stock
Check out the analysis of Mink Therapeutics Correlation against competitors.
For more information on how to buy Mink Stock please use our How to Invest in Mink Therapeutics guide.

Mink Therapeutics Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets6.2 M6.6 M6 M
Slightly volatile
Short and Long Term Debt Total4.2 M4.4 M20 M
Slightly volatile
Other Current Liabilities6.4 M3.8 M5.9 M
Slightly volatile
Total Current Liabilities9.2 M6.3 M8.9 M
Slightly volatile
Other Liabilities327.5 K344.8 K2.2 M
Slightly volatile
Property Plant And Equipment Net771.7 K842.9 K549.3 K
Slightly volatile
Current Deferred Revenue152.8 K171.9 K187.6 K
Slightly volatile
Accounts Payable3.9 M3.1 M3 M
Slightly volatile
Cash5 M5.3 M4.8 M
Slightly volatile
Non Current Assets Total870.5 K842.9 K586.8 K
Slightly volatile
Long Term Debt4.2 M4.4 M20 M
Slightly volatile
Cash And Short Term Investments5 M5.3 M4.8 M
Slightly volatile
Net Receivables19.7 K20.7 K332.1 K
Slightly volatile
Common Stock Shares Outstanding3.6 M4.4 M2.9 M
Slightly volatile
Liabilities And Stockholders Equity6.2 M6.6 M6 M
Slightly volatile
Non Current Liabilities Total15.5 M16.5 M24.7 M
Slightly volatile
Inventory1.5 K1.6 K112.8 K
Very volatile
Other Current Assets504.6 K472.5 K222.4 K
Slightly volatile
Other Stockholder Equity84.3 M144 M40.6 M
Slightly volatile
Total Liabilities24.3 M22.8 M33.4 M
Slightly volatile
Property Plant And Equipment Gross1.1 M1.4 M716.2 K
Slightly volatile
Total Current Assets5.4 M5.7 M5.4 M
Slightly volatile
Capital Stock34.236.0222
Slightly volatile
Non Current Liabilities Other41.1 K43.3 K3.1 M
Pretty Stable
Short Term Debt3.8 M4.3 M4.7 M
Slightly volatile
Common Stock34.236.0213
Slightly volatile
Property Plant Equipment693.7 K1.2 M593.6 K
Slightly volatile
Common Stock Total Equity271305333
Slightly volatile
Capital Surpluse88.7 M99.7 M108.9 M
Slightly volatile
Short Term Investments3.7 B4.1 B4.5 B
Slightly volatile

Mink Therapeutics Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization130.5 K247.8 K83.6 K
Slightly volatile
Interest Expense216.6 K228 K1.3 M
Slightly volatile
Selling General Administrative5.2 B5 B855.5 M
Slightly volatile
Other Operating Expenses15.6 M9.6 M20.5 M
Slightly volatile
Research Development5.4 M5.7 M16.2 M
Slightly volatile
Total Operating Expenses15.5 M9.4 M20.5 M
Slightly volatile
Reconciled Depreciation127.6 K247.8 K82.5 K
Slightly volatile
Cost Of Revenue148.5 K247.8 K95.4 K
Slightly volatile
Interest Income237.1 K155.3 K254.2 K
Very volatile
Non Operating Income Net Other2.2 M2.4 M2.7 M
Slightly volatile

Mink Therapeutics Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation2 M2.1 M987 K
Slightly volatile
Begin Period Cash Flow3.7 M3.9 M6.8 M
Pretty Stable
Depreciation130.5 K247.8 K83.6 K
Slightly volatile
Capital Expenditures3.423.6290.1 K
Slightly volatile
Change To Account Receivables2.1 M1.6 M2.8 M
Slightly volatile
Change To Operating Activities3 M3.5 M5.2 M
Slightly volatile
End Period Cash Flow5 M5.3 M4.8 M
Slightly volatile
Change To Netincome6.7 M3.5 M3.1 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio335377412
Slightly volatile
Days Sales Outstanding223251273
Slightly volatile
Average Payables3.1 M3 M3.3 M
Slightly volatile
Stock Based Compensation To Revenue0.260.290.3133
Slightly volatile
Capex To Depreciation0.00.07.2455
Slightly volatile
EV To Sales366412449
Slightly volatile
Payables Turnover0.07460.07110.0304
Slightly volatile
Sales General And Administrative To Revenue4.445.05.4531
Slightly volatile
Research And Ddevelopement To Revenue22.825.6527.9968
Slightly volatile
Capex To Revenue0.50.560.608
Slightly volatile
Cash Per Share1.051.11.4033
Slightly volatile
Days Payables Outstanding5 K5.3 K16.6 K
Slightly volatile
Income Quality0.510.80.6346
Pretty Stable
Current Ratio0.720.650.4651
Slightly volatile
Receivables Turnover1.051.181.288
Slightly volatile
Capex Per Share0.00.00.1159
Slightly volatile
Revenue Per Share0.230.260.2816
Slightly volatile
Interest Debt Per Share1.441.518.1246
Slightly volatile
Debt To Assets0.940.9912.9218
Slightly volatile
Operating Cycle223251273
Slightly volatile
Days Of Payables Outstanding5 K5.3 K16.6 K
Slightly volatile
Ebt Per Ebit1.31.161.1274
Pretty Stable
Quick Ratio0.720.650.4581
Slightly volatile
Cash Ratio0.680.590.3956
Slightly volatile
Days Of Sales Outstanding223251273
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.121.161.0364
Slightly volatile
Fixed Asset Turnover1.421.591.7352
Slightly volatile
Debt Ratio0.940.9912.9218
Slightly volatile
Price Sales Ratio335377412
Slightly volatile
Asset Turnover0.420.470.5172
Slightly volatile

Mink Therapeutics Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap28.5 M30 M117.7 M
Slightly volatile
Enterprise Value28.9 M30.4 M89 M
Slightly volatile

Mink Fundamental Market Drivers

Mink Upcoming Events

19th of March 2024
Upcoming Quarterly Report
View
9th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
19th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Mink Therapeutics Financial Statements

Mink Therapeutics shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Mink Therapeutics investors may analyze each financial statement separately, they are all interrelated. The changes in Mink Therapeutics' assets and liabilities, for example, are also reflected in the revenues and expenses on on Mink Therapeutics' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue171.9 K152.8 K
Cost Of Revenue247.8 K148.5 K
Stock Based Compensation To Revenue 0.29  0.26 
Sales General And Administrative To Revenue 5.00  4.44 
Research And Ddevelopement To Revenue 25.65  22.80 
Capex To Revenue 0.56  0.50 
Revenue Per Share 0.26  0.23 
Ebit Per Revenue(29.08)(30.54)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Mink Stock Analysis

When running Mink Therapeutics' price analysis, check to measure Mink Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mink Therapeutics is operating at the current time. Most of Mink Therapeutics' value examination focuses on studying past and present price action to predict the probability of Mink Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mink Therapeutics' price. Additionally, you may evaluate how the addition of Mink Therapeutics to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY